This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Sanjay Asopa Joel Dunning Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Patel, A. Articles by Dunning, J. Search for Related Content PubMed PubMed Citation Articles by Patel, A. Articles by Dunning, J. Related Collections Cardiac - pharmacology Education

Should patients receiving a radial artery conduit have post-operative calcium channel blockers?

^a Wessex Cardiothoracic Unit, Southampton General Hospital, Southampton, UK
^b Department of Cardiothoracic Surgery, James Cook University Hospital, Middlesbrough, UK

*Corresponding author. Tel./fax: +44-7801548122.

E-mail address: joeldunning{at}doctors.org.uk (J. Dunning).

A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether calcium channel blockers or possibly nitrates are necessary if a radial artery conduit has been used for coronary artery bypass grafting. The reported search found 98 papers of which 14 represented the best evidence to answer the clinical question. The author, journal, date and country of publication, patient group, relevant outcomes and weaknesses were tabulated. We conclude routine use of calcium channel blockers (CCBs) and nitrates, in order to reduce vasospasm, is in widespread use but none of the clinical studies that we identified provided any evidence for their benefit. Furthermore, one study demonstrated that a vasoconstrictor mediated increase in blood pressure actually increased blood flow in the radial artery, and a further study reported that serotonin induced vasospasm was not attenuated by CCBs in vivo. All these studies are underpowered to exclude a benefit of vasodilators in improving graft patency in the medium term. However, an RCT that sought to prove an increase of 5% in patency rates (which are already around 90% or more) with a power of 80% would have to recruit and perform medium term angiography on 948 patients.

Key Words: Thoracic surgery; Radial artery; Calcium channel antagonists; Coronary arterial bypass graft

This article has been cited by other articles:

				J. Tatoulis, B. F. Buxton, J. A. Fuller, M. Meswani, S. Theodore, N. Powar, and R. Wynne Long-term patency of 1108 radial arterial-coronary angiograms over 10 years. Ann. Thorac. Surg., July 1, 2009; 88(1): 23 - 29. [Abstract] [Full Text] [PDF]

				B. F. Buxton, P. A.R. Hayward, A. E. Newcomb, S. Moten, S. Seevanayagam, and I. Gordon Choice of conduits for coronary artery bypass grafting: craft or science? Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 658 - 670. [Abstract] [Full Text] [PDF]

				R. Ding, W. Feng, H. Li, L. Wang, D. Li, Z. Cheng, J. Guo, and D. Hu A comparative study on in vitro and in vivo effects of topical vasodilators in human internal mammary, radial artery and great saphenous vein Eur. J. Cardiothorac. Surg., September 1, 2008; 34(3): 536 - 541. [Abstract] [Full Text] [PDF]

				H. B. Barner Operative Treatment of Coronary Atherosclerosis Ann. Thorac. Surg., April 1, 2008; 85(4): 1473 - 1482. [Abstract] [Full Text] [PDF]